The FDA says it won’t approve DBV Technologies’ Viaskin Peanut, the novel skin patch allergy desensitization treatment, at least not… Read more »
Tag: viaskin peanut
DBV Cuts Costs Awaiting FDA; Unveils More Peanut Patch Results
With much of the Food and Drug Administration’s staff working on the coronavirus pandemic, the timeline for reviews of some… Read more »
3 in 4 Kids See Benefit From Viaskin Peanut Patch After 3 Years
New results show that after three years of using the Viaskin Peanut patch in children ages 4 to 11, more… Read more »
FDA to Review Viaskin Peanut Patch for Possible Approval
DBV Technologies has announced that the FDA has agreed to review the company’s Viaskin Peanut patch for potential regulatory approval.… Read more »
Patch Progress, Peanut OIT in Adults Data Presented at EAACI Meeting
We’re learning more about the two therapies to treat peanut allergies that could soon be available in allergist’s offices in… Read more »
Peanut Patch Builds Tolerance Better Over Longer Period: Study
In children, Viaskin Peanut built more allergen tolerance when used over two years.
Peanut Patch Shows Promise For Treatment of Allergy
In trials, Viaskin Peanut allowed some participants to tolerate 10 times more peanut protein than at the outset.